• Research and Development

  Real-Life Clinical Setting Reveals Benefits of Esbriet and Ofev

  Posted by Pulmonary Fibrosis News Moderator on October 2, 2018 at 2:37 pm

  Read about a study showing Esbriet or Ofev significantly slowed progression of idiopathic pulmonary fibrosis (IPF) in a real-life setting.

  Click here to find out more about this study here.

  What do you think about this study’s findings?

  replied 6 years, 4 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply